| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short communication |
1 Medical Physics Group, Department of Radiology, University Complutense of Madrid, 28040 Madrid, 2 Medical Physics Service, San Carlos Hospital, 28040 Madrid and 3 Diagnostic Radiology Service, San Carlos Hospital, 28040 Madrid, Spain
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Mapping skin doses is useful to determine the probability of a possible injury and its extent, to detect areas of overlapping radiation fields and to provide the possibility of obtaining a permanent register of the most exposed patient skin areas. This is essential for the follow-up of patients with multiple fluoroscopy interventions, e.g. multiple percutaneous transluminal coronary angioplasties (PTCAs) due to restenosis [3]. To fulfil this task, large films with slow X-ray response can be used. Several types are available: laser printer; duplicating; fine grain positive films; or radiochromic films [4, 5]. One good alternative is the use of slow films such as those for radiotherapy. In a previous paper [6], the authors found that the verification film Kodak X Omat V film (Eastman Kodak, Rochester, NY) is adequate, when correctly calibrated and placed close to the skin, for estimation of skin doses. The procedure is valid for interventions, such as coronary angiography or other cardiac and vascular interventions when the MSD does not exceed 500 mGy. Unfortunately, long and complex procedures usually require a wider measurement range. Recently, Kodak has introduced a new radiotherapy verification film with low radiation sensitivity, named EDR2 (Extended Dose Range). The aim of this paper is to analyse the possibilities of this new film for estimating skin dose distributions in interventions with potentially higher doses, such as complex PTCA, intravascular brachytherapy procedures (IVB) or cardiac ablations.
| Materials and method |
|---|
|
|
|---|
Lumiscan 75 laser film digitizer
The Lumiscan 75 is a tabletop, laser film digitizer designed by Lumisys Inc. (now acquired by Eastman Kodak Company) especially for high-resolution medical imaging requirements. According to manufacturer's indications, the density resolution and precision is a linear function from 0.001 to 3.6 optical density (OD). The unit accommodates film sizes from 8'' x 10'' to 14'' x 17'' and resolutions of up to 2 K x 2.5 K x 12 bits (line pair resolution of 2.8 lp mm-1). This unit is used in the present work to obtain digital images of the patient skin dose maps for further analysis and dose estimations. Figure 1
shows the OD versus grey level calibration that ensures that no significant uncertainties are introduced for dose estimations when the digitalized film is employed.
|
The films calibrated and analysed in the present work are Kodak X-Omat V film and new Kodak EDR2 film:
A Kodak RPX-OMAT, model M6B, 90-s processor was used at the facility exclusively to process slow films, adjusted at the replenishment rate compatible with a low work load and with the developer at the minimum adjustable temperature (31.8°C±0.3°C) to minimize film sensitivity. Kodak RPX-OMAT developer and Kodak RPX-OMAT LO fixer were employed. The processor is under a daily sensitometric quality control.
The X-ray equipment used to obtain a densitometric pattern on the film was a General Electric MPG 50 generator (GE Medical Systems, Waukesha, WI) with a GE MSN 742/200 tube. The measured half value layer was 3.0 mm Al at 80 kVp. Radiation output, exposure time and tube potential accuracy and reproducibility were better than 2%.
Individually calibrated Lithium Fluoride TLD-100 dosimeters from Harshaw (Harshaw, Thermoelectron Co., Berkshire, UK) and a RadCal 2025 radiation meter (RadCal Co., Monrovia, CA) with an external 20 x 6-60 chamber were used to measure film entrance doses.
OD readings were obtained with a digital densitometer Victoreen 07-424 previously calibrated with an ANSI sensitometric strip (Victoreen, Cleveland, OH).
Method for determining the shape of the characteristic curve
To obtain the different experimental points on the characteristic curve the inverse square distance method was employed using both radiographic X-ray and fluoroscopy beams. The tube potential was fixed at 80 kVp (±2%) and an abdomen configuration of an ANSI phantom [7], with 15 cm of polymethyl methacrylate (PMMA) and inserts of 1 mm and 2 mm Al layers, was placed below the slow film to include the contribution from patient backscatter radiation to the film characteristic curve and the speed determination. The radiation field was collimated to obtain an irradiation field size at the film of 11.5 cm x 11.5 cm. Focus to film distances were varied from 45 cm to 100 cm. Additional points on the characteristic curve were obtained by varying the number of radiographic exposures (and the exposure time under fluoroscopy). The film was processed after 2 h using a Kodak M6B automatic processor.
Method for the speed determination
A calibrated external ionization chamber was placed in contact with the film to measure doses. The same geometry, tube potential, irradiation fields and backscatter condition as for the characteristic curve methodology were selected. With an appropriate X-ray radiographic technique, the focus to film distance was varied until a net OD of 2.0 at the film was obtained. The procedure was repeated under X-ray fluoroscopy. Since a possible shift of film response with kV is only expected for the absolute value of the film speed and not for the shape of the characteristic curve, the film sensitivity kV dependence (from 60 kVp to 110 kVp) has been checked using the same methodology as described for speed determination. In this work the speed index was defined as:
|
|
| Results and discussion |
|---|
|
|
|---|
|
Obviously, dose response curves could change from batch to batch and be strongly influenced by processing conditions, thus periodic revision of the calibration curve is advisable to minimize dose uncertainties. Figure 3
shows the variation of speed index with developer temperature. As expected, sensitivity increases with temperature, so it is advisable to work at the lowest possible controlled temperature. Variations of the developer temperature of 0.5°C will change the film speed by about 2%. Dose curves presented in Figure 2
have been obtained at 31.8°C
|
In Figures 4 and 5![]()
some practical differences when using the X-Omat V and the EDR2 film for patient dosimetry of complex PTCAs (with IVB) are shown. IVB usually produces saturated films as long fluoroscopy times and high field concentration are used. Figure 4
shows the irradiation fields registered with the X-Omat V film for a patient undergoing a coronary intervention with a dose area product of 109 Gy cm2, measured with a transmission chamber during the intervention. Figure 5
shows the radiation fields registered with the EDR2 film after a similar intervention with a higher dose area product (238 Gy cm2). The dose map in the first case shows large areas of film saturation (about 300 cm2) in which doses could be higher than 700 mGy. The second case shows no saturation except in an area of 60 cm2, according to the EDR2 characteristic curve that means maximum skin doses over 1400 mGy.
|
|
It would be desirable to establish a follow-up programme for patients whose slow film pattern shows saturation densities and a large concentration of fields. At the cardiology service where this protocol is being implemented, approximately 1% of the images show these characteristics. For those patients, their identification number and resulting slow film image is registered at a database, so that the cardiologist can actually avoid accumulation of doses at the same skin areas, especially for patients with repeated procedures.
| Conclusions |
|---|
|
|
|---|
The global cost of the procedure (about \#8364;4 per film) is low enough with respect to the cost of the interventional procedure to consider the implementation of this methodology in interventional radiology and interventional cardiology services.
| Footnotes |
|---|
Received for publication August 6, 2002. Revision received . Accepted for publication March 10, 2003.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Domienik, S. Papierz, J. Jankowski, J. Z. Peruga, A. Werduch, and W. Religa Correlation of patient maximum skin doses in cardiac procedures with various dose indicators Radiat Prot Dosimetry, December 1, 2008; 132(1): 18 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Tsalafoutas, V. Tsapaki, C. Triantopoulou, C. Pouli, V. Kouridou, I. Fagadaki, and J. Papailiou Comparison of Measured and Calculated Skin Doses in CT-Guided Interventional Procedures Am. J. Roentgenol., November 1, 2008; 191(5): 1601 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Martin RADIATION DOSIMETRY FOR DIAGNOSTIC MEDICAL EXPOSURES Radiat Prot Dosimetry, March 28, 2008; (2008) ncm495v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Tsapaki, C. Triantopoulou, P. Maniatis, S. Kottou, J. Tsalafoutas, and J. Papailiou PATIENT SKIN DOSE ASSESSMENT DURING CT-GUIDED INTERVENTIONAL PROCEDURES Radiat Prot Dosimetry, March 8, 2008; (2008) ncn007v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
R E Morrell and A T Rogers A mathematical model for patient skin dose assessment in cardiac catheterization procedures. Br. J. Radiol., September 1, 2006; 79(945): 756 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Prieto, E Vano, J M Fernandez, C Galvan, M Sabate, L Gonzalez, and D Martinez Six years experience in intracoronary brachytherapy procedures: patient doses from fluoroscopy Br. J. Radiol., September 1, 2006; 79(945): 730 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
R E Morrell and A T Rogers Kodak EDR2 film for patient skin dose assessment in cardiac catheterization procedures. Br. J. Radiol., July 1, 2006; 79(943): 603 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
REFERENCES J. ICRU, December 1, 2005; 5(2): 103 - 113. [Full Text] [PDF] |
||||
![]() |
H. Ohuchi, T. Satoh, Y. Eguchi, and K. Mori Preliminary study of using imaging plates to map skin dose of patients in interventional radiology procedures Radiat Prot Dosimetry, December 1, 2005; 117(4): 432 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Vano, L. Gonzalez, E. Guibelalde, P. Aviles, J. M. Fernandez, C. Prieto, and C. Galvan Evaluation of risk of deterministic effects in fluoroscopically guided procedures Radiat Prot Dosimetry, December 1, 2005; 117(1-3): 190 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Van Dam, H. Bosmans, G. Marchal, and A. Wambersie Characteristics of dosemeter types for skin dose measurements in practice Radiat Prot Dosimetry, December 1, 2005; 117(1-3): 185 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Karambatsakidou, P Tornvall, N Saleh, T Chouliaras, P-O Lofberg, and A Fransson Skin dose alarm levels in cardiac angiography procedures: is a single DAP value sufficient? Br. J. Radiol., September 1, 2005; 78(933): 803 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Guibelalde, L Gonzalez, and E Vano Suitability of resin-coated photographic paper for skin dose measurement during fluoroscopically-guided X-ray procedures Br. J. Radiol., October 1, 2004; 77(922): 871 - 875. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| BJR | DMFR | IMAGING | ALL BIR JOURNALS |